Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy

Cell types differentiated from induced pluripotent stem cells (iPSCs) are frequently arrested in their development program, more closely resembling a fetal rather than an adult phenotype, potentially limiting their utility for downstream clinical applications. The fetal phenotype of iPSC‐derived den...

Descripción completa

Detalles Bibliográficos
Autores principales: Horton, Christopher, Davies, Timothy J., Lahiri, Priyoshi, Sachamitr, Patty, Fairchild, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Embryonic Stem Cells/Induced Pluripotent Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003857/
https://www.ncbi.nlm.nih.gov/pubmed/31621975
http://dx.doi.org/10.1002/stem.3095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003857/
https://www.ncbi.nlm.nih.gov/pubmed/31621975
http://dx.doi.org/10.1002/stem.3095

Ejemplares similares